Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liquidambar styraciflua resin is a natural oily resin (balsam) obtained from the trunk of the Liquidambar styraciflua tree (commonly known as American sweetgum). The resin is secreted when the bark is damaged and collected by scoring and processing the bark. Traditionally called "storax" or "American storax," it has been used in folk medicine for conditions such as stomach pain, eczema, coughs, diarrhea, epilepsy and wound healing; however scientific evidence supporting these uses is lacking[1][5][7]. The main pharmacological activities attributed to this resin are antibacterial and anti-inflammatory effects[1][5]. It has also been used topically as a skin protectant and in perfumery as a fragrance fixative[5][8]. In foods it serves as a flavoring agent. There are no well-documented clinical trials or regulatory approvals for pharmaceutical indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liquidambar styraciflua resin.